SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-19-061157
Filing Date
2019-11-07
Accepted
2019-11-07 16:38:27
Documents
75
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm1919566-1_10q.htm 10-Q 711534
2 EXHIBIT 10.1 tm1919566d1_ex10-1.htm EX-10.1 25254
3 EXHIBIT 31.1 tm1919566d1_ex31-1.htm EX-31.1 10408
4 EXHIBIT 31.2 tm1919566d1_ex31-2.htm EX-31.2 10750
5 EXHIBIT 32.1 tm1919566d1_ex32-1.htm EX-32.1 3847
6 EXHIBIT 32.2 tm1919566d1_ex32-2.htm EX-32.2 4013
13 GRAPHIC tm1919566_logo.jpg GRAPHIC 4599
  Complete submission text file 0001104659-19-061157.txt   6050033

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT nvax-20190930.xml EX-101.INS 1708973
8 XBRL TAXONOMY EXTENSION SCHEMA nvax-20190930.xsd EX-101.SCH 44676
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nvax-20190930_cal.xml EX-101.CAL 46305
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nvax-20190930_def.xml EX-101.DEF 168456
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvax-20190930_lab.xml EX-101.LAB 372599
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvax-20190930_pre.xml EX-101.PRE 321891
Mailing Address 21 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 21 FIRSTFIELD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26770 | Film No.: 191200936
SIC: 2836 Biological Products, (No Diagnostic Substances)